r/r dlbcl: transplant eligibility and r-chop
Published 3 years ago • 125 plays • Length 6:06Download video MP4
Download video MP3
Similar videos
-
10:49
prognosis of r/r dlbcl
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
4:55
how is diffuse large b-cell lymphoma (dlbcl) treated?
-
1:27
dr. yasenchak on brentuximab vedotin added to r-chop in dlbcl
-
8:21
diffuse large b-cell lymphoma (dlbcl) - aggressive b-cell neoplasm - non-hodgkin’s lymphoma
-
7:06
dlbcl: car-t as curative treatment/bridge to transplant
-
2:03
dr. poeschel on 6 versus 4 cycles of r-chop in frontline dlbcl
-
4:01
first- and second-line treatment in dlbcl
-
2:06
car-t therapy vs autologous transplantation in r/r dlbcl
-
4:10
treating relapsed diffuse large b-cell lymphoma
-
5:11
traditional therapies for high-risk lymphoma and efficacy
-
4:09
novel treatment combinations for r/r dlbcl
-
16:21
should r-chop remain the standard of care for dlbcl?
-
1:57
r-chop dose intensity and survival outcomes in dlbcl
-
1:31
car-t therapy versus autosct in dlbcl
-
3:01
candidates for car t-cell therapy in dlbcl
-
2:52
can we offer a curative treatment to transplant-ineligible r/r dlbcl patients?
-
2:57
future directions for r/r dlbcl
-
15:16
debate: how should patients with abc type dlbcl be treated today? - r-chop